,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"cardiac toxicities, acute renal failure, tumor lysis syndrome, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, peripheral neuropathies, insomnia, rash, embolic and thrombotic events, hypertension, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, death."
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, myocardial ischemia, death, Acute Renal Failure, Tumor Lysis Syndrome, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, Posterior reversible encephalopathy syndrome, Embryo-fetal Toxicity"
2,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, prolonged QTc, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, heart failure, hospitalization for heart failure"
4,MULTAQ,warnings and precautions,"atrial fibrillation (AF), liver injury, hepatic injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, cardiovascular death, heart failure, stroke, new onset heart failure, worsening heart failure, hepatocellular liver injury, acute liver failure requiring transplant, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, death"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, serious adverse reactions, treatment discontinuation, hypersensitivity, Gastrointestinal Disorders, Constipation, Vomiting, Increased transaminases, Metabolism and Nutrition disorders, Hypokalemia, Skin and Subcutaneous Tissue Disorders, Vascular Disorders, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Bradycardia, Palpitations, Abdominal pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal failure, Urticaria, Agranulocytosis."
7,TEFLARO,warnings and precautions,"serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, Direct Coombs' test seroconversion, drug-induced hemolytic anemia, development of drug-resistant bacteria, death"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic treatment measures, skin erythema, pruritis, corticosteroids, anti-histamines, thyroid neoplasia"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Effects on serum liver biochemistries, Fat Redistribution, Immune Reconstitution Syndrome, insomnia, fatigue, headache, Treatment-emergent Adverse Drug Reactions, depression, abnormal dreams, dizziness, nausea, diarrhea, rash (includes pooled terms: rash, rash generalized, rash macular, rash maculo-papular, rash pruritic, drug eruption), vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, elevated ALT, elevated AST, elevated cholesterol, elevated creatine kinase, increased hyperglycemia, increased lipase, Grade 3 to 4 treatment-emergent hematology laboratory abnormality, neutropenia, increases in serum creatinine, Grade 2 ADRs (rash, abdominal pain, and diarrhea), elevated total bilirubin, elevated lipase."
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, life-threatening reaction, hepatitis B or C worsening, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Gravesâ€™ disease, polymyositis, Guillain-Barre syndrome"
12,TAFINLAR,adverse reactions,"new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, neoplasms benign, malignant, and unspecified (including cysts and polyps), squamous cell carcinoma of the skin (cuSCC), skin papilloma, cutaneous squamous cell carcinoma, rash, cough, constipation, nasopharyngitis, hypophosphatemia, hyperglycemia, hyponatremia, increased alkaline phosphatase, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation, renal failure"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, cutaneous, non-cutaneous, Tumor promotion in BRAF Wild-Type Melanoma, Hemorrhage, Major hemorrhagic events, signs and symptoms of bleeding, Venous Thromboembolism, Deep vein thrombosis, pulmonary embolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, pyrexia, Serious Skin Toxicity, skin toxicities, secondary infections, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hemolytic anemia, Embryofetal Toxicity, fetal harm, cutaneous squamous cell carcinoma, keratoacanthoma, basal cell carcinoma, melanoma, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, intracranial hemorrhage, gastric hemorrhage, decreased LVEF, RPED, Uveitis, Iritis, intolerable Grade 2 rash, Grade 3 rash, Grade 4 rash, serum glucose level elevation, vision disturbance, syncope, renal failure, dehydration, hypotension, rigors, chills, death"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, confusional state, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"Driving impairment, Somnolence, Sedation, Dizziness, Suicidal thoughts, Suicidal behaviors, Fatigue, Asthenia, Death (due to Drug Reaction with Eosinophilia and Systemic Symptoms or DRESS/Multiorgan Hypersensitivity), Fever, Rash, Lymphadenopathy, Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Eosinophilia, Withdrawal seizure, Pancreatic acinar cell adenoma, Pancreatic acinar cell carcinoma, Breast tumors, Brain tumors, Lung tumors, Adrenal tumor, Non-Hodgkin's lymphoma, Endometrial carcinoma in situ, Prostate tumor"
16,IMBRUVICA,adverse reactions,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, hyperuricemia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, hemoglobin decreased, sinusitis, chills, urinary tract infection, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, gastroesophageal reflux disease, pruritus, arthropathy, skin infection, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, death"
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, fatal bleeding events, Grade 3 or higher bleeding events, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, fever, fatal infections, non-fatal infections, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, Atrial Fibrillation, atrial flutter, palpitations, lightheadedness, dyspnea, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome (TLS), embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, death"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urinary urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, CPK increased, alkaline phosphatase increased, LDH increased, PSA increased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, LDL increased, prothrombin time prolonged, urinary casts, white blood cells in urine, protein in urine, hepatic failure, jaundice, abnormal liver function test, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death."
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, MI, stroke, hepatic failure, fatal hepatic failure, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, drug-induced liver injury, death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
21,CIMZIA,boxed warnings,"serious infections, hospitalization, death, serious infection, sepsis, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, lymphoma, malignancy, tuberculosis (TB), bacterial sepsis, malignancies"
22,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, malignancies, heart failure, worsening of heart failure, new onset of heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, exacerbation of demyelinating disease, new onset of demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, hepatosplenic T-cell lymphoma, acute leukemia, chronic leukemia, worsening congestive heart failure, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatitis B virus reactivation, neurological disorders, seizure disorder, optic neuritis, peripheral neuropathy, blood dyscrasias, significant hematologic abnormalities, leukopenia, thrombocytopenia, aplastic anemia, death"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
24,KALYDECO,warnings and precautions,"elevated transaminases, increased transaminase levels, non-congenital lens opacities, cataracts"
25,FULYZAQ,adverse reactions,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
26,FULYZAQ,warnings and precautions,disease may worsen
27,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus (skin and subcutaneous tissue disorder), hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, airway irritation, transient increases in blood pressure, procedural pain, shortness of breath, death"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, immunogenicity"
30,GRANIX,warnings and precautions,"splenic rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis, Capillary Leak Syndrome, hypotension, hypoalbuminemia, edema, hemoconcentration, death"
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, increased aspartate aminotransferase, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, increased alanine aminotransferase, decreased hematocrit, abnormal lymphocyte morphology, decreased platelet count, increased platelet count, decreased white blood cell count, increased white blood cell count, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, cardiac arrhythmias, bradycardia, severe cardiac disease, sudden death, electrolyte balance disturbances, decreased exposure to lumefantrine, decreased efficacy, decreased bile production, increased concentrations of artemether/lumefantrine, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased risk of adverse effects, recrudescence, severe hepatic impairment, severe renal impairment, relapsing malaria, death"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, Vertigo, Visual impairment, Diarrhea, Constipation, Abdominal pain, Gastritis, Gait disturbance, Peripheral edema, Urinary tract infections, Fall, hyponatremia, Balance disorder, Memory impairment, Nystagmus, Depression, Insomnia, Cough, Hypertension, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"Suicidal Behavior and Ideation, Suicidal thoughts, Suicidal behavior, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Dizziness, Disturbance in gait, Coordination, Somnolence, Fatigue, Cognitive dysfunction, Visual changes, Withdrawal of APTIOM, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Nausea, Vomiting, Dehydration, Gait instability, Seizures, Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Fever, Rash, Lymphadenopathy, Laryngeal edema, Death (associated with DRESS, Anaphylactic Reactions, and Hyponatremia as they can be fatal or life-threatening), Obtundation, Injury, Hypochloremia, Ataxia, Vertigo, Balance disorder, Gait disturbance, Nystagmus, Abnormal coordination, Asthenia, Malaise, Hypersomnia, Sedation, Lethargy, Memory impairment, Disturbance in attention, Amnesia, Confusional state, Aphasia, Speech disorder, Slowness of thought, Disorientation, Psychomotor retardation, Diplopia, Blurred vision, Impaired vision, Elevated transaminases, Increased bilirubin, Jaundice, Decreased serum T3, Decreased serum T4."
35,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, death, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH"
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, abdominal infections, urinary tract infections, ear infections, endocarditis"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, Pyrexia, Headache, Peripheral Edema, Nausea, Hypokalemia, Tremor, Rash, Constipation, Pneumonia, Sepsis, Device-related Infection, Encephalopathy, Overdose, Confusion, Staphylococcal Bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal Pain, Vomiting, Fatigue, Chills, Chest Pain, Blood and Lymphatic System Disorders, Gastrointestinal Disorders, General Disorders and Administration Site Conditions, Immune System Disorders, Infections and Infestations, Investigations, Metabolism and Nutrition Disorders, Musculoskeletal and Connective Tissue Disorders, Nervous System Disorders, Psychiatric Disorders, Respiratory, Thoracic, and Mediastinal Disorders, Skin and Subcutaneous Tissue Disorders, Vascular Disorders, Leukocytosis, Lymphopenia, Cardiac Disorders, Tachycardia, Edema, Cytokine Storm, Decreased Immunoglobulins, Increased Blood Bilirubin, Increased Gamma-Glutamyl-Transferase, Increased Liver Enzymes, Tumor Lysis Syndrome, Hypoalbuminemia, Encephalopathy, Paresthesia, Aphasia, Convulsion, Memory Impairment, Cognitive Disorder, Speech Disorder, Confusion, Disorientation, Capillary Leak Syndrome, Hypersensitivity, Bronchospasm, Hypotension, Hypertension, Death"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, life-threatening, fatal, Neurological toxicities, severe, death"
39,BLINCYTO,warnings and precautions,"infections, effects on ability to drive and use machines, preparation and administration errors, cytokine release syndrome (CRS), life-threatening, fatal, infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome (TLS), neutropenia, febrile neutropenia, seizures, loss of consciousness, elevated liver enzymes, Grade 3 or greater elevations in liver enzymes, leukoencephalopathy, preparation and administration errors, underdose, overdose, death"
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, ophthalmologic, Non-arteritic anterior ischemic optic neuropathy (NAION), decreased vision, permanent loss of vision."
41,STENDRA,warnings and precautions,"hypotension, erection lasts greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, tinnitus, dizziness, prolonged erection greater than 4 hours, priapism (painful erections greater than 6 hours in duration), penile tissue damage, permanent loss of potency, myocardial infarction, stroke, life-threatening arrhythmia, coronary revascularization, resting hypotension, hypertension, unstable angina, angina with sexual intercourse, congestive heart failure, symptomatic hypotension (e.g., dizziness, lightheadedness, fainting), headache, bleeding disorders, active peptic ulceration, anti-aggregatory effect"
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, flexor tendon rupture, tenderness, injection site swelling, injection site edema, injection site pruritus, axillary mass, blood blister, injection site hematoma, ecchymosis, penile ""popping"" sounds or sensations, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, penile blister, blood blister, penile ecchymoses"
43,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, penile ""popping"" sensation, severe penile hematoma, surgical intervention, death"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, permanent injury, ligament damage, skin laceration, corporal rupture (penile fracture), hypersensitivity reactions, anaphylaxis, abnormal coagulation, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, tear, penile ecchymoses, hematoma, sudden penile detumescence, severe penile hematoma, allergic reactions, pruritus, injection site hemorrhage, ecchymosis/contusion, bleeding"
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, blepharospasm, eye disorder, facial paresis (brow ptosis), muscle disorder (elevation of eyebrow), eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, corneal exposure, corneal ulceration, reduced blinking, ectropion, ptosis, asthenia, generalized muscle weakness, diplopia, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, respiratory failure, death"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous Skin Disorders, Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, Serious adverse reactions, dyspnea, fatigue, hypokalemia, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, Gastrointestinal disorders, Cheilitis, Skin and subcutaneous tissue disorders, Infections and infestations, Cystitis, Metabolism and nutrition disorders, Respiratory, thoracic and mediastinal disorders, Epistaxis, Rhinorrhea, Investigations, Weight Decreased, General disorders and administration site conditions, Pyrexia, Eye disorders, Conjunctivitis, Alanine aminotransferase increased, Aspartate aminotransferase increased, Postmarketing Experience, Pancreatitis, death"
49,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, severe diarrhea, prolonged diarrhea, anti-diarrheal agents, Bullous Skin Disorders, Exfoliative Skin Disorders, severe bullous lesions, blistering, exfoliating lesions, life-threatening cutaneous reactions, Interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, Hepatic toxicity, fatal hepatic impairment, liver test abnormalities, liver function worsening, severe hepatic impairment, Keratitis, acute eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, suspected keratitis, ulcerative keratitis, severe dry eye, Embryofetal toxicity, fetal harm, embryotoxic, abortions, contraception, reproductive potential, death"
50,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, worsening hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, pruritus, bilirubin elevations, increased AST, increased ALT, creatinine level changes, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, weight decreased, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
51,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, anaphylaxis, infusion reactions, severe anaphylactic reactions, tumor lysis syndrome, acute renal failure, skin reactions, severe skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, other malignancies, pre-malignant diseases, malignant diseases, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasation injury, erythema, swelling, pain, infection, necrosis, neutropenic sepsis, diffuse alveolar hemorrhage, thrombocytopenia, pneumonia from opportunistic infection (CMV), sepsis, septic shock, chills, pruritus, rash, bullous exanthema, allergic-type reactions, toxic skin reactions."
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"imaging errors, allergic reactions, anaphylaxis, radiation risk, poor imaging performance, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, increased risk for cancer."
54,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, allergic reactions, thrombotic events, hepatobiliary disorders, pancreatic disorders, hyperglycemia, hemorrhagic events, anti-drug antibodies (ADA)"
55,ERWINAZE,warnings and precautions,"serious hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal Pain, Decreased Appetite, Dyspepsia, Fatigue, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Symptomatic hypoglycemia, Severe hypoglycemia, Heart Rate Increase, Tachycardia, Immunogenicity, Injection-site reactions, PR Interval Prolongation, First Degree Atrioventricular (AV) Block, Amylase and Lipase Increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"Thyroid C-cell tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Acute renal failure, Worsening of chronic renal failure, Severe gastrointestinal reactions, Death"
59,ADREVIEW,adverse reactions,"serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, norepinephrine uptake blockade, norepinephrine store depletion, withdrawal signs, withdrawal symptoms, serious reactions, benzyl alcohol toxicity, Gasping Syndrome, hypotension, metabolic acidosis, kernicterus, death, increased radiation exposure, decreased image quality, scintigraphic imaging errors, hypertension"
61,DOTAREM,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, Acute kidney injury, Nausea, Headache, Injection site pain, Injection site coldness, Burning sensation, Feeling cold, Rash, Somnolence, Fatigue, Dizziness, Vomiting, Pruritus, Paresthesia, Dysgeusia, Pain in extremity, Anxiety, Hypertension, Palpitations, Oropharyngeal discomfort, Serum creatinine increased, Injection site inflammation, Injection site extravasation, Injection site pruritus, Injection site warmth, Bradycardia, Tachycardia, Arrhythmia, Cardiac arrest, Respiratory arrest, Cyanosis, Pharyngeal edema, Laryngospasm, Bronchospasm, Angioedema, Conjunctivitis, Ocular hyperemia, Eyelid edema, Lacrimation increased, Hyperhidrosis, Urticaria, Coma, Convulsion, Syncope, Presyncope, Parosmia, Tremor, Muscle contracture, Muscle weakness, Diarrhea, Salivary hypersecretion, Malaise, Fever, Superficial phlebitis"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis affecting the skin, muscle and internal organs, chronic, severe kidney disease, acute kidney injury, death"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, Hypersensitivity, Anaphylactoid reactions, Anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, cardiorespiratory support, chronic severe kidney disease, acute kidney injury, debilitating fibrosis, renal function reduction, drug-induced kidney toxicity, NSF, circulatory collapse, bronchial asthma, allergic disorders, Acute Kidney Injury, tissue irritation, Extravasation, Injection Site Reactions"
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, hemorrhagic stroke, intracranial hemorrhage, subarachnoid hemorrhage, subdural hemorrhage, gastrointestinal bleeds, major bleeding, intracerebral hemorrhage, fatal bleeding, ICH, non-intracranial fatal bleed, abdominal pain upper, abdominal discomfort, epigastric discomfort, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer, death."
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, paralysis, neurological impairment, death"
66,PRADAXA,warnings and precautions,"Bleeding, fatal bleeding, thrombotic events, pathological bleeding, increased risk of bleeding, blood loss, active pathological bleeding, renal impairment, epidural or spinal hematoma, long-term or permanent paralysis, neurological impairment, midline back pain, sensory and motor deficits, numbness, tingling, weakness in lower limbs, bowel and/or bladder dysfunction, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, hemodynamic compromise, death."
67,ELIQUIS,adverse reactions,"Increased risk of thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, intracranial hemorrhage, gastrointestinal bleed, fatal bleeding, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, prophylaxis of deep vein thrombosis, prophylaxis of pulmonary embolism, reduction of risk of stroke, systemic embolism, nonvalvular atrial fibrillation, hip replacement surgery, knee replacement surgery, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, increased transaminases, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, postprocedural bleeding, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis, neurological impairment, death"
69,ELIQUIS,warnings and precautions,"serious bleeding, fatal bleeding, blood loss, thrombotic events, stroke, pathological bleeding, active pathological hemorrhage, epidural hematoma, spinal hematoma, long-term paralysis, permanent paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction, bleeding, death"
70,ZERBAXA,adverse reactions,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, death, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase, increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, renal and urinary system, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis"
71,ZERBAXA,warnings and precautions,"decreased efficacy, serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, development of drug-resistant bacteria, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death, infection"
74,FERRIPROX,warnings and precautions,"agranulocytosis, neutropenia, infection, fetal harm, embryofetal death, malformations, increased ALT values, increased AST values, decreased plasma zinc concentrations, death"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma"
76,DALVANCE,warnings and precautions,"serious hypersensitivity, anaphylactic reactions, skin reactions, rapid intravenous infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea (CDAD), flushing of the upper body, urticaria, pruritus, rash, liver test abnormalities, ALT elevation, AST elevation, bilirubin elevation, mild diarrhea, fatal colitis, fluid and electrolyte management issues, protein supplementation necessities, development of drug-resistant bacteria, death"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, post-inhalation cough, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
78,ARCAPTA,boxed warnings,"asthma-related death, death"
79,ARCAPTA,warnings and precautions,"acutely deteriorating COPD, cardiovascular effects, fatal, death, immediate hypersensitivity reactions, paradoxical bronchospasm, life-threatening paradoxical bronchospasm, asthma-related death, asthma exacerbation, deterioration of disease, acute episodes, excessive use, cardiovascular effects, cardiac arrhythmias, hypertension, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, hypokalemia, hyperglycemia, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, increase in pulse rate, increases in systolic or diastolic blood pressure, difficulties in breathing, swelling of tongue, lips and face, urticaria, skin rash"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"ECG Changes, Potential for Cardiac Arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval, cardiac arrhythmias, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, Anaphylactic shock, Respiratory arrest, Pulmonary edema, Bronchospasm, Cyanosis, Oropharyngeal swelling, Laryngeal edema, Blood pressure increased, Chest pain, Angioedema, Conjunctivitis, Hyperhidrosis, Cough, Sneezing, Burning sensation, Pallor, Headache, Nausea, Dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypotension, Urticaria, Face edema, Eyelid edema, Flushing, Dyspnea, Paresthesia, Loss of consciousness, Convulsion, Parosmia, Tachycardia, Palpitation, Dry mouth, Malaise, Feeling cold, Cardiac arrest, death"
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic severe kidney disease, Acute kidney injury, reduced renal function, death."
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, higher than recommended dosing, repeated dosing, anaphylactic reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, mild reactions, severe reactions, death, chronic severe kidney disease, acute kidney injury, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, rapid decrease in kidney function, surgery-induced kidney toxicity, severe infection-induced kidney toxicity, injury-induced kidney toxicity, drug-induced kidney toxicity, chronically reduced renal function, NSF risk increase with repeated/higher doses, recommended dose excess, acute kidney injury requiring dialysis, moderate irritation due to extravasation, overestimation of extent of malignant disease."
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, dose reductions, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy (paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy), vision disorder (vision impairment, blurred vision, photopsia, accommodation disorder, presbyopia, reduced visual acuity), prolonged QT interval, hemoglobin decreased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin increased, death"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, liver laboratory tests, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, death, Embryofetal Toxicity, elevated transaminases, jaundice, elevations in alanine aminotransferase (ALT), elevations in total bilirubin, ventricular tachyarrhythmias, Torsade de pointes, sudden death, elevate lipase, elevate amylase, skeletal anomalies."
87,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, nausea, hepatotoxicity, ILD, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, neuropathy, rash, renal cyst, syncope, gait disturbance, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, acute respiratory distress syndrome, arrhythmia, dyspnea, pneumonia, pneumonitis, respiratory failure, sepsis, asthenia, weight decreased, hypokalemia, hypophosphatemia, neutropenia, lymphopenia, ALT elevation, AST elevation, dysesthesia, hypoesthesia, peripheral neuropathy, parasthesia, burning sensation in skin, hepatic failure"
88,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, death, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, concurrent elevations in ALT and AST, elevation in ALT, elevation in AST, transaminase elevations, elevated transaminases, liver function tests abnormalities, Hepatotoxicity with fatal outcome, QTc prolongation, Grade 3 or 4 ILD, fatal ILD, QTcF greater than or equal to 500 ms, ECG changes, congestive heart failure, bradyarrhythmias, electrolyte abnormalities, Torsade de pointes, polymorphic ventricular tachycardia, heart rate less than 50 beats per minute, Grade 3 syncope, symptomatic bradycardia, life-threatening bradycardia, optic atrophy, optic nerve disorder, vision loss, embryotoxicity, fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
90,BEPREVE,warnings and precautions,"contamination, contact lens-related irritation"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal and neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
95,POTIGA,boxed warnings,"retinal abnormalities, vision loss, damage to the photoreceptors, abnormal visual acuity, decreased visual acuity, progression of retinal abnormalities, reversibility unknown"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, neuropsychiatric symptoms, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, suicidal behaviors, retinal abnormalities, potential vision loss, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, hydronephrosis, renal function impairment, dysuria, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, widespread skin discoloration, discoloration of the palate, discoloration of the sclera, discoloration of conjunctiva, psychosis, urinary hesitation, withdrawal seizures"
97,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, itching, death"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, bleeding, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, serum liver test abnormalities, hepatobiliary laboratory abnormalities, portal vein thromboses, abdominal pain, toothache, AST increased, vitamin D deficiency, ALT increased, ecchymosis, muscle spasms, arthralgia, rhinorrhea, pain in extremity, dyspnea, dizziness, febrile neutropenia, abdominal pain, transaminases increased, cytogenetic abnormalities, thrombotic microangiopathy with acute renal failure, death"
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"hepatotoxicity, thrombotic/thromboembolic complications, portal vein thrombosis, hepatic decompensation, ascites, encephalopathy, liver enzyme elevations, indirect hyperbilirubinemia, increased direct bilirubin, clinical symptoms of liver injury, hepatic decompensation, thrombotic event, venous and arterial events, cataracts, abdominal pain, nausea, vomiting, diarrhea."
102,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula formation, hypothyroidism, thyroid hormone replacement, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm, death"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular events, hyperpyrexia, confusion, symptoms exacerbation in ischemic heart disease, arrhythmias exacerbation, congestive heart failure exacerbation, allergic reactions, bronchial asthma, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, death"
107,JARDIANCE,adverse reactions,"hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), urinary tract infection, female genital mycotic infections, asymptomatic bacteriuria, cystitis, vulvovaginal mycotic infection, vaginal infection, vulvitis, vulvovaginal candidiasis, genital infection, genital candidiasis, genitourinary tract infection, vulvovaginitis, cervicitis, urogenital infection fungal, vaginitis bacterial, polyuria, pollakiuria, nocturia, balanoposthitis, balanitis, genital infections fungal, balanitis candida, scrotal abscess, penile infection, Upper respiratory tract infection, Increased urination, Dyslipidemia, Arthralgia, Nausea, Thirst, Volume Depletion, dehydration, hypovolemia, orthostatic hypotension, syncope, Impairment in Renal Function, serum creatinine increase, eGFR decrease, Hypoglycemia, phimosis, Increase in Low-Density Lipoprotein Cholesterol, Increase in Hematocrit"
108,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, congestive cardiac failure, acute cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, allergic conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, conjunctival hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, general edema, pitting edema, edema due to cardiac disease, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, iron deficiency anemia, leukopenia, anemia."
110,FANAPT,boxed warnings,"increased mortality, death, dementia-related psychosis, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome (NMS), tardive dyskinesia, hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, dyslipidemia, undesirable alterations, weight gain, metabolic changes, seizures, orthostatic hypotension, dizziness, tachycardia, syncope, leukopenia, neutropenia, agranulocytosis, suicide, priapism, cognitive impairment, motor impairment, hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, mammary gland proliferative changes, body temperature regulation disruption, dysphagia, aspiration pneumonia, somnolence, sedation"
112,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, Atrial Fibrillation/Flutter, Appendicitis, Immunogenicity, Liver Enzyme Abnormalities, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)"
114,TANZEUM,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment,acute pancreatitis, severe abdominal pain, vomiting, pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, nausea, diarrhea, dehydration."
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, death, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal tear, corneal edema, injection site hemorrhage."
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, Neutropenia, Anemia, Leukopenia, Thrombocytopenia, Diarrhea, Fatigue, Nausea, Vomiting, Constipation, Asthenia, Abdominal Pain, Hematuria, Back Pain, Anorexia, Peripheral Neuropathy, Pyrexia, Dyspnea, Dysgeusia, Cough, Arthralgia, Alopecia, Infections, Renal Failure, Ventricular Fibrillation, Cerebral Hemorrhage, Dyspnea, Cardiac Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, Sepsis, Septic Shock, Gastritis, Intestinal Obstruction, death."
118,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths, death, hypersensitivity, generalized rash/erythema, hypotension, bronchospasm, severe hypersensitivity reactions."
119,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, sepsis, septic shock, grade 3-4 neutropenia, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, nausea, vomiting, severe diarrhea, diarrhea-related mortality, gastrointestinal hemorrhage, gastrointestinal perforation, ileus, enterocolitis, neutropenic enterocolitis, abdominal pain, tenderness, persistent constipation, renal failure, renal failure with fatal outcomes, fetal harm, embryotoxicity, fetotoxicity, abortifacient, death"
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, Hepatotoxicity, Dermatitis, Neuropathy, Endocrinopathy, Hypopituitarism, Adrenal insufficiency, Pneumonitis, Meningitis, Nephritis, Eosinophilia, Pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), death"
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, immune-mediated adverse reactions, severe immune-mediated adverse reactions, fatal immune-mediated adverse reactions, T-cell activation and proliferation, death"
122,YERVOY,warnings and precautions,"severe immune-mediated reactions, fatal immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, liver function test abnormalities, immune-mediated endocrinopathies, thyroid function test abnormalities, immune-mediated enterocolitis, severe enterocolitis, life-threatening enterocolitis, fatal enterocolitis, moderate enterocolitis, intestinal perforation, complications leading to death, hospitalization for severe enterocolitis, fever, ileus, peritoneal signs, diarrhea, abdominal pain, mucus in stool, blood in stool, hepatotoxicity, fatal hepatic failure, hospitalization for hepatotoxicity, AST elevations, ALT elevations, total bilirubin elevations, immune-mediated dermatitis, toxic epidermal necrolysis, Stevens-Johnson syndrome, rash complicated by full thickness dermal ulceration, necrotic dermatitis, bullous dermatitis, hemorrhagic dermatitis, dermatitis requiring hospitalization, severe dermatitis, moderate dermatitis, rash, pruritus, immune-mediated neuropathies, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, motor neuropathy, sensory neuropathy, paresthesia, weakness, immune-mediated endocrinopathies requiring hospitalization, urgent medical intervention, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, immune-mediated ocular disease, death."
123,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Nasopharyngitis, Urinary Tract Infections, Back Pain, Increased Urination, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with Urination, Pain in Extremity, Volume Depletion (including reports of dehydration, hypovolemia, orthostatic hypotension, hypotension), Renal Failure, Increases in Serum Creatinine, Decreases in eGFR, Renal Impairment-Related Adverse Reactions, Blood Creatinine Increase, Bone Fractures, Asthenia, Hypersensitivity Reactions (e.g., angioedema, urticaria, hypersensitivity, anaphylactic reactions, severe cutaneous adverse reactions), Increase in Hematocrit, Increase in Serum Inorganic Phosphorus."
124,FARXIGA,warnings and precautions,"hypotension, renal function impairment, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer, death"
125,PICATO,adverse reactions,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"eye disorders, severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
127,PRISTIQ,adverse reactions,"Hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, lipid abnormalities, proteinuria, systolic orthostatic hypotension, Stevens-Johnson syndrome, death (if a fatal event is listed)."
128,PRISTIQ,boxed warnings,"suicidal thoughts, behaviors, worsening, emergence of suicidal thoughts and behaviors"
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, elevated blood pressure, hypertension, abnormal bleeding, bleeding events, Angle Closure Glaucoma, Activation of Mania, Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, suicidal thoughts and behaviors, suicidality, unusual changes in behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, psychomotor restlessness, dizziness, nausea, vomiting, diarrhea, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dysphoric mood, sensory disturbances, paresthesia, electric shock sensations, confusion, headache, lethargy, emotional lability, tinnitus, difficulty concentrating, memory impairment, weakness, unsteadiness, falls, hallucination, syncope, respiratory arrest, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Urine RBC, Proteinuria, increased serum creatinine, decreased estimated creatinine clearance, Bone Mineral Density, bone fractures, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, death"
131,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, death"
132,STRIBILD,warnings and precautions,"new onset or worsening renal impairment, acute renal failure, Fanconi syndrome, decreased creatinine clearance, increased urine glucose, increased urine protein, decreased serum phosphorus, lactic acidosis, severe hepatomegaly with steatosis, fatal cases (death), hepatotoxicity, hepatomegaly and steatosis, pathologic fracture, bone loss, osteoporosis, decreases in bone mineral density (BMD), redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, proximal renal tubulopathy, persistent or worsening bone pain, pain in extremities, fractures, muscular pain, weakness, osteomalacia, arthralgias, hypophosphatemia, inflammation of opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion-related reactions, hypotension, hypertension, proteinuria, immunogenicity, antibodies against belatacept, neutralizing antibodies, NODAT, dyslipidemia, hypercholesterolemia, hypertriglyceridemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hypophosphatemia, hyperglycemia, hypocalcemia, hypomagnesemia, hyperuricemia, renal tubular necrosis, hematuria, dysuria, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death"
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder, malignancies, serious infections, increased susceptibility to infection, possible development of malignancies, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), malignancies, Progressive Multifocal Leukoencephalopathy (PML), serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy (PVAN), kidney graft loss, liver transplant not recommended, graft loss, death, acute rejection, corticosteroid minimization, immunosuppression management issues, other serious infections, cytomegalovirus (CMV), herpes, Pneumocystis jiroveci infections, BK virus infection, deteriorating renal function, increased risk with corticosteroid minimization, increased rate and grade of acute rejection, Grade III rejection, Avoidance of live vaccine use during treatment."
136,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, muscle twitching, edema, peripheral, rash papular, flu-like illness, chills, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, death."
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, exacerbation of cardiac compromise, exacerbation of respiratory compromise, death"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated cutaneous reactions, necrotizing skin lesions, type III immune-mediated reactions, inflammatory arthropathy, fever, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, cardiac arrest, death, cardiac resuscitation, defibrillation, immunogenicity, reduced clinical efficacy, loss of motor function, ventilator dependence, IgE-mediated reactions, inhibitory antibody activity."
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, elevation of serum bilirubin, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, death, chronic severe kidney disease, acute kidney injury, reduced renal function"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis (NSF), impaired elimination of GBCAs, higher than recommended dosing, repeated dosing, Hypersensitivity, anaphylactoid reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, need of emergency cardiorespiratory support, acute kidney injury, surgery, severe infection, injury, drug-induced kidney toxicity, rapid decrease in kidney function, reversible decrease in kidney function, serum creatinine levels unreliability, estimated GFR unreliability, chronically reduced renal function, repeated doses of GBCA, high doses of GBCA, degree of renal impairment, hemodialysis, Anaphylactic reactions, allergic disorders, bronchial asthma, history of a reaction to contrast media, increased risk for hypersensitivity reaction, trained personnel for resuscitation, Delayed reactions, signs and symptoms of hypersensitivity, Acute Kidney Injury, Extravasation, local tissue reactions, intramuscular administration, myocyte necrosis, inflammation, Interference with Laboratory Tests, falsely high or low values for serum iron determination, Interference with Visualization of Liver Lesions, severe renal failure, hepatic failure, reduced hepatic contrast, elevated serum ferritin levels, high serum bilirubin levels, death (as NSF may result in fatal or debilitating fibrosis)."
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, febrile neutropenia, ventricular fibrillation"
143,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, nausea, vomiting, diarrhea, teratogenicity, embryo-fetal lethality, death"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"birth defects, fetal death, anemia, decrease in hemoglobin concentrations, neutropenia, hypersensitivity, urticaria, angioedema, pancytopenia, serious acute hypersensitivity reactions, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, dyspnea, exertional dyspnea, dizziness, syncope, severe or life-threatening infections associated with neutropenia, life-threatening neutropenia, death"
146,VIMIZIM,adverse reactions,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue"
147,VIMIZIM,boxed warnings,"anaphylactic reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions, acute respiratory illness, acute exacerbation of respiratory compromise, death"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, life-threatening anaphylaxis, life-threatening complications, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute febrile, acute respiratory complications, acute reaction, severe hypersensitivity reactions, severe reaction, sleep apnea, extreme drowsiness, spinal or cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence, death"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, Transaminases Increased, rash, Blood Amylase Increased, death"
150,SIRTURO,boxed warnings,"Increased Mortality, death, QT Prolongation, ventricular arrhythmia, QTcF interval >500 ms"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, hepatotoxicity, liver injury, increased mortality, death, Clinically significant ventricular arrhythmia, syncope, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, adverse reactions"
152,NEURACEQ,adverse reactions,"erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, long-term cumulative radiation exposure, increased risk of cancer, unintentional radiation exposure."
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, vomiting, dysphagia, dyspepsia, hemorrhoids, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, pneumonia, septicemia, cardiac arrest, respiratory failure, death."
155,COMETRIQ,boxed warnings,"perforations, fistulas, gastrointestinal perforations, fistula formation, hemorrhage, severe hemorrhage, fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage, death"
156,COMETRIQ,warnings and precautions,"thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolic events, wound complications, dehiscence, hypertension, hypertensive crisis, osteonecrosis of the jaw, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration, gingival erosion, slow healing of the mouth, slow healing of the jaw, Palmar-plantar erythrodysesthesia syndrome (PPES), Proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), seizures, headache, visual disturbances, confusion, altered mental function, Gastrointestinal (GI) perforations, fistulas, GI fistula, tracheal/esophageal fistula, Hemorrhage, hemoptysis, death"
157,AFINITOR,adverse reactions,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hypercholesterolemia, hyperglycemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, dyspnea, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, stomatitis, mouth ulceration, aphthous stomatitis, glossodynia, gingival pain, glossitis, lip ulceration, pneumonitis, interstitial lung disease, lung infiltration, pulmonary fibrosis, hyperglycemia, nasal congestion, urinary tract infection, upper respiratory tract infection, pneumonia, bronchitis, cystitis, sinusitis, candidiasis, sepsis, hepatitis C, vomiting, constipation, dry mouth, edema peripheral, pyrexia, weight decreased, hyperglycemia, arthralgia, pain in extremity, headache, muscle spasms, dyspnea, dry skin, nausea, vomiting, abdominal pain, diabetes mellitus, hypertension, renal failure, thrombotic events, dyspnea exertional, pleural effusion, pharyngolaryngeal pain, rhinorrhea, muscle spasms, dyspnea, dry skin, acne, dry mouth, hemorrhoids, dysphagia, impaired wound healing, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, hemoglobin decreased, WBC decreased, lymphocytes decreased, neutrophils decreased, glucose increased, cholesterol increased, phosphate decreased, triglycerides increased, calcium decreased, potassium decreased, creatinine increased, sodium decreased, bilirubin increased, potassium increased, hyperglycemia, lymphopenia, hypophosphatemia, hypercholesterolemia, neutropenia, phosphate decreased, triglycerides increased, urticaria, menstrual irregularities, vaginal hemorrhage, hypersensitivity, ovarian cyst, pneumonitis, elevated partial thromboplastin time, elevated creatinine, hypoglycemia, cellulitis, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, death"
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, death, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, vaccinations, avoid live vaccines, embryo-fetal toxicity, fetal harm, non-specific respiratory signs and symptoms, hypoxia, pleural effusion, cough, dyspnea, opportunistic infections, pneumocystis jiroveci pneumonia (PJP), pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, viral infections, reactivation of hepatitis B virus, sepsis, respiratory failure, hepatic failure, swelling of the airways, tongue swelling, respiratory impairment, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased lymphocytes, drug-drug interactions, hepatic impairment, therapeutic drug monitoring"
159,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, oropharyngeal candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, death."
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, increased risk of asthma-related hospitalization, death"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, overdose, Candida albicans infection, mouth and pharynx infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, death"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Urinary Tract Infections, Increased Urination, Male Genital Mycotic Infections, Vulvovaginal Pruritus, Thirst, Constipation, Nausea, Abdominal Pain, Fatigue, Asthenia, Pancreatitis, Erythema, Rash, Pruritus, Urticaria, Angioedema, Photosensitivity Reactions, Photosensitivity Reaction, Polymorphic Light Eruption, Sunburn, Volume Depletion-Related Adverse Reactions, Hypotension, Postural Dizziness, Orthostatic Hypotension, Syncope, Dehydration, Falls, Increased Blood Creatinine, Decreased Glomerular Filtration Rate, Renal Impairment, Acute Renal Failure, Vulvovaginal Mycotic Infection, Vulvovaginal Candidiasis, Vulvovaginitis, Candidal Balanitis, Balanoposthitis, Phimosis, Circumcision, Severe Hypoglycemia, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Hemoglobin, Decreases in Bone Mineral Density"
165,INVOKANA,warnings and precautions,"hypotension, renal impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, immunogenicity, anti-glucarpidase antibodies, neutralizing antibodies, death"
167,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions, death"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, death"
169,NESINA,warnings and precautions,"acute pancreatitis, serious hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, severe and disabling arthralgia, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, Liver transaminase elevation, Diarrhea, Cough, Influenza, Sinusitis, Back pain, Abdominal pain, Pain in extremity, Serum transaminase elevations, Basal cell carcinoma, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Dizziness, Pneumonia, Eczema, Pruritus, Ischemic and hemorrhagic strokes, Peripheral arterial occlusive disease, Lymphoma."
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), Liver injury, Blood pressure (BP) increase, Bradyarrhythmia, Atrioventricular Blocks, Reduction in Heart Rate, bradyarrhythmia, hypotension, dizziness, fatigue, palpitations, chest pain, second-degree AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, death, syncope, herpes zoster, bronchitis, influenza, sinusitis, pneumonia, Herpes Viral Infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, Cryptococcal infections, cryptococcal meningitis, Varicella Zoster Virus, macular edema, blurred vision, decreased visual acuity, visual disturbances, posterior reversible encephalopathy syndrome, headache, altered mental status, seizure, Respiratory Effects, dyspnea, unexplained dyspnea, Elevations of liver enzymes, nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine, Fetal Risk, Immune System Effects, lymphocyte counts decrease, hypertension, additive immunosuppressant effects."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
173,HALAVEN,warnings and precautions,"neutropenia, severe neutropenia, Grade 4 neutropenia, febrile neutropenia, peripheral neuropathy, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, sensory neuropathy, motor neuropathy, embryo-fetal toxicity, fetal harm, teratogenicity, QT prolongation, hyperkalemia, hypomagnesemia, death"
174,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, DRESS, hepatic failure, rhabdomyolysis, toxic epidermal necrolysis, death"
175,INTELENCE,warnings and precautions,"Severe skin reactions, potentially life threatening reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 and 4 rashes, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, Immune reconstitution syndrome, inflammatory response, indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, injection site haemorrhage, injection site irritation, injection site pain, feeling cold, chills, anxiety, back pain, claustrophobia, dizziness, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"Image interpretation errors, false negatives, Radiation risk, increased risk of cancer, unintentional radiation exposure."
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"gasping syndrome, eye irritation, contact dermatitis, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, drug interactions, loss of efficacy, serious depression, suicidal ideation, suicidal behavior, attempted suicide, death"
182,ILARIS,adverse reactions,"upper respiratory tract infections, infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, rhinitis, hypersensitivity reactions, decreased white blood cells, neutrophils and platelets, elevated transaminases, elevated bilirubin"
183,ILARIS,warnings and precautions,"serious infections, increased risk of serious infections, upper respiratory tract infections, unusual infections, opportunistic infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, immunosuppression, increased risk of malignancies, hypersensitivity reactions, hypersensitivity, anaphylactic reactions, immune response interference, ineffective vaccinations, macrophage activation syndrome (MAS), life-threatening disorder, death"
184,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraine, breast pain, menstrual disorders, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, abdominal pain, acne, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, arterial thrombosis, venous thrombosis, venous thromboembolism (VTE), arterial thromboses, strokes, myocardial infarctions, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, retinal vascular lesions, retinal vein thrombosis, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, hypertension, gallbladder disease, decreased glucose tolerance, adverse lipid changes, hypertriglyceridemia, pancreatitis, headache, severe headache, migraine, breakthrough bleeding, spotting, irregular bleeding, amenorrhea, oligomenorrhea, depression, chloasma, death"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
188,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, drug-resistant bacteria"
189,ONFI,adverse reactions,"somnolence, sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, vomiting, dysphagia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, sedation, psychomotor hyperactivity, dysarthria, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, blurred vision, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema"
190,ONFI,warnings and precautions,"Somnolence, Sedation, CNS depression, Withdrawal symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, Physical Dependence, Psychological Dependence, Suicidal Behavior, Suicidal Ideation, Convulsions, Psychosis, Hallucinations, Behavioral Disorder, Tremor, Anxiety, Dysphoria, Insomnia, Depression, Mood Changes, Self-Harm."
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin in urine, erythema, dyspepsia, aspartate aminotransferase increased, elevated hepatic transaminases, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, Progressive multifocal leukoencephalopathy (PML), death, lymphopenia, decreased lymphocyte counts, infections, serious infections, progressive weakness on one side of the body, clumsiness of limbs, disturbance of vision, changes in thinking, memory, and orientation leading to confusion and personality changes, flushing, warmth, redness, itching, burning sensation, serious flushing symptoms, hospitalization"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity, accommodation issues, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, breathing difficulties, dyspnea, blood glucose increase, electrocardiographic changes, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site numbness, injection site erythema, injection site tenderness, injection site tingling, injection site itching, injection site stinging, injection site warmth, injection site irritation, injection site tightness, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, excessive granulation tissue, sensation of heaviness, gait disturbance, hypertonia, antibody formation, immunogenicity."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, exacerbation of clinical effects of treatment, risk for transmission of Creutzfeldt-Jakob disease, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, critical loss of breathing capacity, respiratory failure, facial anatomy alterations, excessive weakness, atrophy, marked facial asymmetry, inflammation, ptosis, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, severe dysphagia from typical doses, transmission of viral diseases, Intradermal immune reaction."
196,ZYTIGA,adverse reactions,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, joint discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, constipation, groin pain, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis, death"
197,ZYTIGA,warnings and precautions,"Mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III or IV heart failure, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, liver enzymes increase, drug interruption, dose modification, treatment discontinuation, hepatic impairment, ALT increase, AST increase, bilirubin increase, liver function tests increase, edema, myocardial infarction, ventricular arrhythmia, adrenal insufficiency, stress, ALT or AST increases (at least 5* ULN), baseline ALT or AST elevated, liver test elevation, serum transaminases increase, serum bilirubin levels increase, AST or ALT rise above five times the ULN, bilirubin rises above three times the ULN"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, all-cause mortality (death), serious adverse reactions, hot flush, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, increased risk of endometrial hyperplasia, stroke, deep vein thrombosis (DVT), unusual vaginal bleeding, blood clots, cancer of the uterus, heart attack, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, asthma, diabetes, epilepsy, migraines, genetic problem called porphyria, lupus, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, hypertriglyceridemia, pancreatitis, probable dementia, elevated blood pressure, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive impairment, motor impairment, body temperature regulation, suicide, dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, toothache, arthralgia, pain in extremity, headache, depression, edema peripheral, tachycardia, glossodynia, abdominal pain, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, choking, oropharyngeal muscular dysfunction, death"
202,SAPHRIS,boxed warnings,"increased mortality, death"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, metabolic changes, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, hemodynamic effects, dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive impairment, Motor impairment, Suicide, death, hyperprolactinemia, Galactorrhea, amenorrhea, gynecomastia, impotence, hypoestrogenism, hypogonadism, decreased bone density, somnolence, sedation, hypersomnia, Body Temperature Regulation, pyrexia, feeling hot, Dysphagia, aspiration pneumonia, myocardial infarction, unstable heart disease, cardiac arrhythmias, bradycardia, hypokalemia, hypomagnesemia, congenital prolongation of the QT interval, Torsade de Pointes, sudden death."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, scleral hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, cornea perforations, sclera perforations, bacterial infections, secondary ocular infections, acute purulent conditions, viral infections, exacerbation of viral infections, herpes simplex infections, fungal infections, persistent corneal ulceration, corneal ulceration."
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, hepatotoxicity, death"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, death"
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising, immunogenicity, seroconversion, antibodies to KALBITOR, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions"
211,KALBITOR,warnings and precautions,"hypersensitivity reactions, anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate or severe hepatic impairment, hepatotoxicity, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS (acute respiratory distress syndrome), toxic epidermal necrolysis, death"
213,ADCETRIS,boxed warnings,"PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY, PML, JC virus infection, death"
214,ADCETRIS,warnings and precautions,"peripheral neuropathy, neuropathy, sensory neuropathy, motor neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, severe neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, hepatocellular injury, increased transaminases, increased bilirubin, progressive multifocal leukoencephalopathy (PML), pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, fetal harm, fetal malformations, death"
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"growth of resistant organisms, overgrowth of non-susceptible organisms, super-infection, bacterial conjunctivitis"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
219,XTANDI,adverse reactions,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, falls, fall-related injuries, hypertensive crisis, death"
220,XTANDI,warnings and precautions,"seizure, brain injury with loss of consciousness, transient ischemic attack, cerebral vascular accident, brain metastases, brain arteriovenous malformation, sudden loss of consciousness, death"
221,BOSULIF,adverse reactions,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, hemoglobin low, lipase increased, phosphorus low, total bilirubin increased, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, bronchitis, influenza, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, death"
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Drug Induced Liver Injury, ALT Elevation, AST Elevation, Transaminase Elevations, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Renal Toxicity, Decrease in eGFR, On-Treatment Decline in eGFR, Embryofetal Toxicity, Fetal Harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, brain injury/damage, death"
225,SIMPONI,adverse reactions,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, Liver Enzyme Elevations, ALT elevations, acute liver failure, Autoimmune Disorders, Autoantibodies, lupus-like syndrome, ANA-positive, anti-dsDNA antibodies, Administration Reactions, infusion reaction, Immunogenicity, antibodies to golimumab, neutralizing antibodies, Other Adverse Reactions, Infections and Infestations, Viral infections, Bacterial infections, Vascular disorders, Skin and subcutaneous disorders, General disorders and administration site conditions, Pyrexia, Blood and lymphatic disorders, Leukopenia, Superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, Nervous system disorders, Dizziness, paresthesia, Gastrointestinal disorders, Constipation, Neoplasm Benign and Malignant, Melanoma, Immune System Disorders, anaphylactic reaction, sarcoidosis, Respiratory, thoracic and mediastinal disorders, Interstitial lung disease, Skin and subcutaneous tissue disorders, Skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis, bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, Legionella, Listeria, lymphoma, malignancies"
227,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, Hepatitis B reactivation, Malignancies, Heart failure, Demyelinating disease, Hypersensitivity reactions, Anaphylaxis, Opportunistic infections, bacterial infections, mycobacterial infections, viral infections, parasitic infections, Aspergillosis, Blastomycosis, Candidiasis, Coccidioidomycosis, Histoplasmosis, Legionellosis, Listeriosis, Pneumocystosis, Tuberculosis, Sepsis, active tuberculosis, Tuberculosis reactivation, Hepatosplenic T-cell lymphoma (HSTCL), Melanoma, Merkel cell carcinoma, Non-melanoma skin cancer (NMSC), Congestive heart failure (CHF), Central nervous system (CNS) demyelinating disorders, Multiple sclerosis (MS), Peripheral demyelinating disorders, Guillain-Barre syndrome, Optic neuritis, Peripheral demyelinating polyneuropathy, Pancytopenia, Leukopenia, Neutropenia, Aplastic anemia, Thrombocytopenia, death"
228,BENLYSTA,adverse reactions,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, infusion reactions, erythematous rash, pruritus, eyelid edema, headache, dyspnea, fatal anaphylaxis, death."
229,BENLYSTA,warnings and precautions,"death, infections, serious infections, fatal infections, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, Progressive Multifocal Leukoencephalopathy (PML), neurological deficits, malignancies, non-melanoma skin cancers, hypersensitivity reactions, anaphylaxis, rash, nausea, fatigue, myalgia, headache, facial edema, angioedema, urticaria, pruritus, dyspnea, infusion reactions, bradycardia, hypotension, depression, suicidality, insomnia, anxiety, serious psychiatric events, serious depression, suicidal thoughts, mood changes"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, palpitations, blurred vision, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
231,TOVIAZ,warnings and precautions,"angioedema, life-threatening, urinary retention, severe constipation, narrow-angle glaucoma, CNS effects, headache, dizziness, somnolence, hepatic impairment, renal impairment, death"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"myocardial infarction,death"
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, death"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"Hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, cancer, motion artifacts."
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events, discontinuation, confusional state."
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, severe allergic reactions, respiratory compromise, urticaria, angioedema, urinary tract infections"
239,ADCETRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity with severe renal impairment, increased toxicity with moderate or severe hepatic impairment, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, embryo-fetal toxicity, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, pancreatitis, interstitial lung disease, ARDS, toxic epidermal necrolysis, hyperglycemia, death."
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, anaphylactic reactions, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, death, increased radiation exposure, false negative imaging results, withdrawal symptoms, toxicity, ""Gasping Syndrome"", hypertension"
241,AFINITOR,all-concat,"Non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, death, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, hypercholesterolemia, leukopenia, thrombocytopenia, lymphopenia, anemia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, grade 3/4 laboratory abnormalities, lymphopenia, hyperglycemia, anemia, decreased potassium, increased AST, increased ALT, thrombocytopenia, respiratory distress, cardiac arrest, hepatic failure, pneumonia, sepsis, pulmonary embolism, hypoglycemia, myocardial infarction, congestive heart failure, sudden death, renal angiomyolipoma, respiratory tract infection, renal angiomyolipoma with TSC, subependymal giant cell astrocytoma (SEGA) with TSC, respiratory tract infection, pyrexia, pneumonia, gastroenteritis, aggression, agitation, amenorrhea, elevated partial thromboplastin time, neutropenia, hypercholesterolemia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, muscular spasms, thrombocytopenia, musculoskeletal and connective tissue disorders, acne, pneumonitis, angioedema with ACE inhibitors, menstrual irregularities, vaginal hemorrhage, dry mouth, chills, pleural effusion, pharyngolaryngeal pain, rhinorrhea, erythema, onychoclasis, skin lesion, acneiform dermatitis, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, abdominal pain, hematologic disorders, glucose increased, cholesterol increased, aspartate transaminase increased, alanine transaminase increased, triglycerides increased, albumin decreased, creatinine increased, hemoglobin decreased, white blood cell (WBC) decreased, platelets decreased, lymphocytes decreased, neutrophils decreased, alkaline phosphatase increased, bicarbonate decreased, phosphate decreased, calcium decreased, sodium decreased, bilirubin increased, potassium increased, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state, death"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritus, urticaria, flushing"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, rash, dysarthria, falls, urinary tract infections, ear and labyrinth disorders, eye disorders, visual impairment, gastrointestinal disorders, diarrhea, constipation, abdominal pain, gastritis, general disorders, administration site conditions, gait disturbance, peripheral edema, infections and infestations, injury, poisoning, procedural complications, metabolism and nutrition disorders, infections and infestations, psychiatric disorders, depression, insomnia, respiratory disorders, cough, skin disorders, subcutaneous tissue disorders, vascular disorders, hypertension, decreases in hemoglobin, hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase, cognitive dysfunction, memory impairment, nystagmus, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, laryngeal edema, serious nausea/vomiting, dehydration, severe gait instability, injury, seizures, malaise, lethargy, confusion, irritability, muscle weakness/spasms, obtundation, balance disorder, hypersomnia, sedation, lethargy, visual changes, impaired vision, elevated bilirubin, elevated transaminases, decreases in serum T3 and T4 (free and total)."
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, Peripheral Edema, cough, thrombocytopenia, pruritus, chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, headache, Infusion Site Pain, hypokalemia, Prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, febrile neutropenia, leukopenia (neutropenia and lymphopenia), serious and fatal infections, sepsis, hepatic toxicity, liver function test abnormalities, teratogenicity, embryo-fetal lethality, genotoxicity"
247,BENLYSTA,all-concat,"Mortality, death, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, Progressive Multifocal Leukoencephalopathy (PML), suicidality, live vaccines, other biologic therapies, intravenous cyclophosphamide."
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death."
251,BOSULIF,all-concat,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, gastric hemorrhage, upper gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, abnormal hepatic function, liver disorder, liver injury, drug hypersensitivity, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, embryofetal toxicity, death"
252,BREO,all-concat,"asthma-related death, death, hospitalization, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, oropharyngeal candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, back pain, pneumonia, arthralgia, influenza, pharyngitis, pyrexia, Candida albicans infection, paradoxical bronchospasm, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, glaucoma, cataracts, hypokalemia, hyperglycemia"
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury/damage, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias, death"
255,CHOLINE,all-concat,"mild injection site reaction, Imaging errors, allergic reactions, anaphylaxis, Radiation risks, increased risk for cancer, blood PSA levels < 2 ng/mL poor imaging performance, false positive results, false negative results, Tissue inflammation, prostatic hyperplasia false positive images, interference with PET imaging by concomitant colchicine, interference with PET imaging by androgen-deprivation therapeutic drugs."
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, tuberculosis, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, legionella, listeria, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, Guillain-Barre syndrome, seizure disorder, peripheral neuropathy, aplastic anemia, hepatosplenic T-cell lymphoma, leukemia, lymphoma, Hodgkin's lymphoma, death"
257,CLEVIPREX,all-concat,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation, reflex tachycardia, negative inotropic effects, exacerbate heart failure, rebound hypertension"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, bullous eruption, death"
259,COMETRIQ,all-concat,"Perforations and Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, septicemia, pneumonia, cardiac arrest, respiratory failure, unspecified death, hemorrhage, hemoptysis, gastrointestinal hemorrhage, myocardial infarction, cerebral infarction, dehiscence, hypertensive crisis, nephrotic syndrome, embryofetal toxicity, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration or erosion, slow healing of the mouth or jaw, vomiting, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, death."
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, increased hepatic transaminases, increased blood alkaline phosphatase, increased international normalized ratio, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, anaphylactic reaction, Red-Man Syndrome, ALT elevations, CDAD (Clostridium difficile-associated diarrhea), fatal colitis, death"
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, erythema, skin erythema, injection site pain, anaphylactic reactions, hypersensitivity risks, thyroid neoplasia, death"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, dyspnea, angioedema, hypersensitivity reactions, death"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death"
264,DUAVEE,all-concat,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, Venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, PROBABLE DEMENTIA, stroke, deep vein thrombosis (DVT), probable dementia, gallbladder problems, loss of vision, high blood pressure, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, visual abnormalities, retinal vascular thrombosis, Elevated Blood Pressure, Hypothyroidism, Fluid Retention, Hypocalcemia, Hereditary Angioedema, Exacerbation of Other Conditions, Laboratory Test Interactions, Impaired glucose tolerance, death (as mentioned in the incidence of all-cause mortality with DUAVEE group and placebo group)."
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, perforation of the globe, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual acuity and fields of vision, delayed healing, incidence of bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"muscular weakness, dysphagia, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity, accommodation, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, dyspnea, ECG measurements, heart rate reduction, eye disorders, blood present in urine, cough, blood triglycerides increased, hypertension, breathing difficulty, infection, influenza, pharyngolaryngeal pain, contact dermatitis, injection site swelling, injury, bruising, haemorrhage, erythema, haematoma, dysphagia, gait disturbance, hypertonia, sensation of heaviness, back pain, diarrhea, constipation, syncope, hypoaesthesia, partial seizures, asthenia, convulsion, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, excessive granulation tissue, death"
267,EDARBI,all-concat,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, hematocrit, low RBC counts, low and high markedly abnormal platelet counts, low and high markedly abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, injury, death, oliguria, progressive azotemia, acute renal failure, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure"
268,ELIQUIS,all-concat,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, intracranial bleed, gastrointestinal (GI) bleed, fatal bleeding, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, death, Intracranial (ICH), Hemorrhagic stroke, Gastrointestinal (GI), Intracranial bleed, Non-intracranial bleed, Hypersensitivity reactions, Spinal/Epidural anesthesia or puncture, reduction of risk of stroke, systemic embolism, nonvalvular atrial fibrillation, Increased risk of thrombotic events, Prosthetic heart valves, Acute PE, Hemodynamically Unstable Patients, patients who require thrombolysis, pulmonary embolectomy, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, gastrointestinal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea and vomiting, diarrhea, death"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, Nausea, Headache, Feeling hot, Dizziness, Back pain, Vomiting, Blood pressure increased, Injection site reactions (pain, burning, coldness, extravasation, irritation), Dysgeusia, Paresthesia, Flushing, Parosmia, Pruritus (generalized, eye), Rash, Respiratory disorders (dyspnea, respiratory distress), Fatigue, Chest pain, Vertigo, Dry mouth, Chills, Feeling abnormal, Tremor, Akathisia, Bundle branch block, Palpitation, Oral discomfort, Salivary hypersecretion, Maculopapular rash, Hyperhidrosis, Discomfort, Malaise, Anaphylactic shock, Hypotension, Pharyngolaryngeal edema, Urticaria, Face edema, Rhinitis, Conjunctivitis, Abdominal pain, Hypoesthesia, Sneezing, Cough, Pallor, Tachycardia, Restlessness, Death"
271,ERWINAZE,all-concat,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, thrombosis, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergic reactions, coagulopathy, infarct, hyperlipidemia, ketoacidosis, CNS events, infarction, cerebral venous thrombosis, allergic reactions, thrombotic events, hepatobiliary disorders, pancreatic disorders, hyperglycemia, anti-drug antibodies, anaphylaxis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, fibrinogen decreased, protein C activity decreased, protein S activity decreased, anti-thrombin III decreased, serious hypersensitivity reactions, severe pancreatitis, mild pancreatitis, irreversible glucose intolerance, serious thrombotic events"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, retinal detachment, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, death, arthralgia, musculoskeletal stiffness, vision blurred, nausea, dry mouth, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, dizziness, somnolence, extrapyramidal disorder, tremor, lethargy, ejaculation failure, nasal congestion, dyspnea, rash, hypotension, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, neuroleptic malignant syndrome (NMS), tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, seizures, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, temperature regulation, dysphagia, suicide, priapism, cognitive and motor impairment"
274,FARXIGA,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, serious anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol (LDL-C)"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, fetal harm, embryofetal death, malformations, death"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
277,FULYZAQ,all-concat,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, anaphylactoid, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury, death"
279,GILENYA,all-concat,"bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, bronchitis, herpes zoster, tinea versicolor, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, heart rate decrease, hypotension, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV block, Mobitz Type I, AV block, 2:1 AV block, third-degree AV block, junctional escape, transient asystole, syncope, herpes viral infections, disseminated primary herpes zoster, herpes simplex encephalitis, varicella zoster, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, JC virus, death (from herpetic infections), forced expiratory volume decrease, diffusion lung capacity for carbon monoxide decrease, fetal harm, increased systolic pressure, increased diastolic pressure, lymphocyte count decrease, immune system effects."
280,GILOTRIF,all-concat,"diarrhea, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, cheilitis, rash, erythema, acneiform rash, palmar-plantar erythrodysesthesia syndrome, bullous skin disorders, blistering, exfoliating lesions, interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, hepatic toxicity, liver test abnormalities, keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, severe dry eye, embryofetal toxicity, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, pancreatitis, renal failure, dehydration, death"
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome (acute febrile neutrophilic dermatosis), cutaneous vasculitis, thrombocytopenia, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, anaphylaxis, severe sickle cell crises, death"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, peripheral motor neuropathy, polyneuropathy, peripheral sensory neuropathy, paresthesia, cytopenias, G-CSF use, GM-CSF use, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
283,HORIZANT,all-concat,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, increased appetite, vertigo, depression, decreased libido, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/multiorgan hypersensitivity, withdrawal seizure, insomnia, asthenia, weight increased, confusional state, suicidal behavior, suicidal ideation, carcinoma, tumor"
284,ILARIS,all-concat,"upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, infections (general), vertigo, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, abdominal pain (upper), mild injection site reaction, moderate injection site reaction, hypersensitivity reactions, decreased white blood cells, decreased neutrophils, decreased platelets, high ALT, high AST, elevated serum bilirubin, tuberculosis, malignancies, anaphylactic reactions, macrophage activation syndrome (MAS), death"
285,IMBRUVICA,all-concat,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, Thrombocytopenia, Neutropenia, Diarrhea, Anemia, Fatigue, Musculoskeletal pain, Bruising, Nausea, Upper respiratory tract infection, Rash, Peripheral edema, Dyspnea, Constipation, Abdominal pain, Vomiting, Decreased Appetite, Pneumonia, Skin infections, Pyrexia, Asthenia, Petechiae, Muscle spasms, Arthralgia, Cough, Epistaxis, Dehydration, Dizziness, Headache, Stomatitis, Dyspepsia, Sinusitis, Urinary tract infection, Subdural hematoma, Lethargy, Gait instability, Hyperuricemia, Intracranial hemorrhage, Elevated uric acid levels, Second malignancies, Skin cancers, Chromosome instability, Renal failure, Increases in creatinine, Lymphocytosis, Headache, Arthropathy, Gastroesophageal reflux disease, Pruritus, Arthralgia, Contusion, Vision blurred, Blurred vision, Hypersensitivity reactions, Anaphylactic shock, Urticaria, Angioedema, Progressive multifocal leukoencephalopathy (PML), Non-skin carcinomas, Non-melanoma skin cancer, Embryo-Fetal Toxicity, Malformations, Reduced fetal weights, Death."
286,INLYTA,all-concat,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hypertensive crisis, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, elevation of liver enzymes, hepatic impairment, fetal development, cerebrovascular accident, myocardial infarction, retinal artery occlusion, cerebral hemorrhage, hematuria, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, hypocalcemia, hyperglycemia, hypernatremia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia, death."
287,INTELENCE,all-concat,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, rash, Stevens-Johnson syndrome, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), toxic epidermal necrolysis, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, tuberculosis, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, renal function abnormalities, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, volume depletion-related adverse reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, angioedema, erythema, rash, pruritus, urticaria, photosensitivity reaction, polymorphic light eruption, sunburn, fatigue, asthenia, pancreatitis, abdominal pain, urinary tract infections, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, increases in serum potassium, severe elevation of serum potassium, increases in serum magnesium, increases in serum phosphate, increases in low-density lipoprotein cholesterol (LDL-C), increases in non-high-density lipoprotein cholesterol (non-HDL-C), increases in hemoglobin, decreases in bone mineral density"
289,JARDIANCE,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), dyslipidemia, arthralgia, nausea, thirst, volume depletion, increased urination, polyuria, pollakiuria, nocturia, blood pressure decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, serum creatinine increase, eGFR decrease, overall hypoglycemic events, severe hypoglycemic events, vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis, phimosis, asymptomatic bacteriuria, cystitis, chronic urinary tract infections, recurrent urinary tract infections, LDL-C increase, hematocrit increase, macrovascular risk reduction failure."
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, infections, ventricular fibrillation, cerebral hemorrhage, Febrile Neutropenia, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, Sepsis, Septic Shock, Gastritis, intestinal obstruction, rash/erythema, bronchospasm, Neutropenic deaths, Gastrointestinal hemorrhage, Gastrointestinal perforation, neutropenic enterocolitis, ileus, enterocolitis, death."
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, blood pressure increased, vasodilation, dizziness, rash, urticaria, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, death"
293,KALYDECO,all-concat,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, bacteria in sputum, arthralgia, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, non-congenital lens opacities/cataracts"
294,KYPROLIS,all-concat,"cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, cardiac arrest, acute renal failure, renal failure, tumor lysis syndrome, pulmonary toxicity, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, hypertensive emergency, venous thrombosis, deep vein thrombosis, pulmonary embolism, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, PRES, Reversible Posterior Leukoencephalopathy Syndrome, RPLS, embryo-fetal toxicity, fetal harm, anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), increase in serum transaminases, leukopenia, neutropenia, lymphopenia, back pain, arthralgia, pain in extremity, musculoskeletal pain, dyspnea, hypocalcemia, hyperglycemia, dehydration, headache, dizziness, peripheral neuropathies, insomnia, pruritus, rash, fever, chills, asthenia, muscle spasms, vomiting, weakness, syncope, chest tightness, angina, blurred vision, urinary tract infection, abdominal pain, abdominal pain upper, dyspepsia, toothache, multi-organ failure, bronchitis, nasopharyngitis, cataract, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, hypomagnesemia, hypophosphatemia, musculoskeletal chest pain, myalgia, hypoesthesia, paresthesia, deafness, dysphonia, oropharyngeal pain, erythema, hyperhidrosis, death."
295,LUMIZYME,all-concat,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, flu-like illness, chills, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, chest pain/discomfort, angioedema, bradycardia, bronchospasm, throat tightness, hypotension, pruritus, local swelling, diarrhea, edema peripheral, papular rash, immune-mediated reactions, flank pain, death"
296,MULTAQ,all-concat,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, premature discontinuation because of adverse reactions, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, death, stroke, heart failure, increase in serum creatinine, pre-renal azotemia, acute renal failure, hepatocellular liver injury, acute liver failure requiring transplant, marked increase in serum creatinine, dyspnea, non-productive cough, renal impairment and failure, fetal harm."
297,NATAZIA,all-concat,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, headache (including migraines), breast tenderness, pain, menstrual disorders, nausea or vomiting, acne, mood changes, increased weight, study discontinuation, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, weight increased, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous and arterial thromboembolic events (pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction, stroke), hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms (abdominal pain), vulvovaginal candidiasis, death"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, hypoglycemia, death"
299,NEURACEQ,all-concat,"injection site reaction, erythema, irritation, pain, image interpretation errors, false positives, unintended radiation exposure, long-term cumulative radiation exposure, increased risk of cancer, severe brain atrophy, motion artifacts, image distortion, death"
300,NORTHERA,all-concat,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease, Arrhythmias, Congestive Heart Failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, Falls, Urinary Tract Infections, Syncope, Allergic Reactions, Death"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, hypertension, proteinuria, immunogenicity, anti-belatacept antibodies, neutralizing antibodies, new-onset diabetes after transplantation (NODAT), dyslipidemia, urinary tract infection, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hyperkalemia, hypokalemia, hypophosphatemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, peripheral edema, anemia, leukopenia, hematuria, proteinuria, dysuria, renal tubular necrosis, hypertension, hypotension, cough, dyspnea, blood creatinine increased, arthralgia, back pain, headache, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death"
302,ONFI,all-concat,"somnolence, sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, constipation, pyrexia, lethargy, drooling, vomiting, dysphagia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis, convulsions, psychosis, behavioral disorder, tremor, status epilepticus, dysphoria, motor dysfunction, CNS depression, mood changes, self-harm, death"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, depression, suicidal thoughts, suicidal behavior, bronchitis, tooth abscess, folliculitis, sinus headache, back pain, insomnia, frequent bowel movements, death"
304,PICATO,all-concat,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, anaphylaxis, death"
305,POTIGA,all-concat,"retinal abnormalities, vision loss, vision changes, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, suicidal ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, retinal pigmentary abnormalities, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy, hydronephrosis, skin abnormalities, scleral discoloration, nail discoloration, mucous membrane discoloration, risk of untreated illness, morbidity and mortality, depression, mood changes, unusual changes in mood or behavior, thoughts of self-harm, worsening of depression, suicidal thoughts, worsening of mood or behavior, signs and symptoms of depression, reduced visual acuity, perivascular pigmentation, bone spicule pattern, focal retinal pigment epithelium clumping, decreased visual acuity, abnormalities in the electroretinogram, abnormalities in the electrooculogram, abnormal fluorescein angiography, diminished sensitivity on visual field testing, visual acuity testing, pulled analyses of suicidal thinking or behavior, retinal dystrophy, risk of untreated illness, morbidity and mortality, renal function impairment."
306,PRADAXA,all-concat,"serious adverse reactions, bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, major bleeding, decrease in hemoglobin, transfusion of packed red blood cells, bleeding at a critical site, fatal outcome, death, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleeding, subdural bleeding, gastrointestinal bleeding, non-intracranial fatal bleeding, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, esophageal ulcer, thrombotic events, spinal/epidural hematoma, thromboembolic events, valve thrombosis, transient ischemic attack, pericardial effusions, thrombocytopenia"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, vomiting, headache, dry mouth, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, increase in fasting serum total cholesterol, LDL cholesterol, triglycerides, Proteinuria, Sustained hypertension, Supine systolic bp increase, Supine diastolic bp increase, Supine pulse increase, Weight decrease, Orthostatic hypotension, Stevens-Johnson syndrome, death (due to mentioning of suicidal thoughts and behaviors, fatal events including myocardial infarction and ischemic cardiac adverse reactions)."
308,PROLIA,all-concat,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, death, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, cataracts, parathyroid hormone elevation, hypersensitivity reactions, drug-related hypersensitivity reactions, anaphylaxis, facial swelling, erythema, severe symptomatic hypocalcemia, severe bone, joint, muscle pain, suppression of bone turnover"
309,PROMACTA,all-concat,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, hepatic enzyme elevations, pain in extremity, dyspnea, dizziness, febrile neutropenia, abdominal pain, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, thrombotic microangiopathy, acute renal failure, portal vein thrombosis, ascites, encephalopathy, serum liver test abnormalities, indirect hyperbilirubinemia, thrombosis, Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease, portal venous system events, portal vein thrombosis"
310,QUTENZA,all-concat,"application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, transient increases in blood pressure"
311,SAPHRIS,all-concat,"dementia-related psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hyperglycemia, Dyslipidemia, Weight Gain, Hypersensitivity Reactions, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Cerebrovascular Adverse Events, death, stroke, transient ischemic attack, anaphylaxis, angioedema, increased mortality, choking, oropharyngeal muscular dysfunction, hypoesthesia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, oral ulcers, blisters, peeling, sloughing, inflammation, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, oral paresthesia, dysgeusia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, arthralgia, pain in extremity, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, muscle strain, hyperinsulinemia, ALT increased, AST increased, myalgia, parkinsonism, suicidal ideation, anger, gynecomastia, tachycardia, bradycardia, cardiac dysrhythmia, tightness of the throat, dyspnea, wheezing, sedation, hypersomnia, dyskinesia, dystonia, oculogyration, muscle rigidity, parkinsonism, tremor, bradykinesia, protrusion tongue, resting tremor, diabetic ketoacidosis, hyperosmolar coma, myocardial infarction, ischemic heart disease, heart failure, conduction abnormalities, dehydration, hypovolemia, hyponatremia, hypokalemia, hypomagnesemia"
312,SIMPONI,all-concat,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, serious infections, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, newly ANA-positive, anti-dsDNA antibodies, administration reactions, infusion reaction, immunogenicity, antibodies to SIMPONI ARIA, adverse drug reactions, viral infections, bacterial infections, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, pyrexia, blood and lymphatic disorders, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, melanoma, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin exfoliation, bullous skin reactions, hepatitis B reactivation, heart failure, demyelinating disease, hepatosplenic T-cell lymphoma (HSTCL), Merkel cell carcinoma, congestive heart failure (CHF), new onset CHF, central nervous system (CNS) demyelinating disorders, multiple sclerosis (MS), peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, pancytopenia, aplastic anemia, thrombocytopenia, hematologic cytopenias, vaccinations, therapeutic infectious agents, disseminated infections, hypersensitivity reactions, anaphylactic or other serious allergic reaction, death"
313,SIRTURO,all-concat,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, Transaminases Increased, rash, Blood Amylase Increased, aminotransferase elevations, alanine aminotransferase increased, aspartate aminotransferase increased, death"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, non-arteritic anterior ischemic optic neuropathy (NAION), change in color vision, sudden loss of vision, priapism, sudden decrease or loss of hearing, death."
315,STRIBILD,all-concat,"lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, peripheral neuritis, neuropathy, anxiety, increased cough, rhinitis, hyperpigmentation on palms or soles, AST elevation, ALT elevation, amylase elevation, creatine kinase elevation, hematuria, bone mineral density decrease, bone fractures, proteinuria, increased serum creatinine, decreased estimated creatinine clearance, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, hepatic steatosis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
316,TAFINLAR,all-concat,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome (PPES), chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, cutaneous squamous cell carcinoma (cuSCC), basal cell carcinoma, melanoma, hypersensitivity manifesting as bullous rash, interstitial nephritis, pancreatitis, vision blurred, transient blindness, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperhidrosis, hypertension, vision disturbances, QT Prolongation, Leukopenia, Lymphopenia, Neutropenia, Anemia, Thrombocytopenia, Increased AST, Increased alkaline phosphatase, Increased ALT, Hyperbilirubinemia, Increased GGT, Hyponatremia, Hypoalbuminemia, Hypophosphatemia, Hypokalemia, Increased creatinine, Hypomagnesemia, Hyperkalemia, Hypercalcemia, Hypocalcemia, Retinal vein occlusion, Interstitial lung disease, Renal failure, uveitis, iritis, dehydration, death"
317,TANZEUM,all-concat,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial Fibrillation, Atrial Flutter, Appendicitis, Immunogenicity, Liver Enzyme Abnormalities, Alanine aminotransferase increase, Gamma Glutamyltransferase increase, Heart Rate Increase, Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)"
318,TECFIDERA,all-concat,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy (PML), lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albuminuria, erythema, dyspepsia, increased aspartate aminotransferase, increased alanine aminotransferase, eosinophilia, death"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis, death"
320,TIVICAY,all-concat,"hypersensitivity reactions, serum liver biochemistries affected, hepatitis B or C co-infection, fat redistribution, immune reconstitution syndrome, death, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, completion, renal impairment, pruritus, ALT elevations, AST elevations, creatine kinase elevations, hyperglycemia, lipase elevations, total neutrophils elevations, cholesterol abnormalities, HDL cholesterol abnormalities, LDL cholesterol abnormalities, triglycerides abnormalities, total bilirubin elevations, immune reconstitution syndrome, transaminase elevations, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to infections, autoimmune disorders (such as Graves' disease, polymyositis, Guillain-Barre syndrome)"
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, death"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, extravsation injury, pyrexia, nausea, vomiting, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, weight decreased, fever, anorexia, dyspnea, rash, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, bilirubin elevations, increased AST, increased ALT, renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia, taste disorder, atypical pneumonia, sepsis, herpes zoster, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), febrile neutropenia, pneumonia, hypokalemia, dehydration, tachycardia, constipation, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, oral candidiasis, weight decreased, anorexia, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, cough, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, rash, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, neutropenic sepsis, diffuse alveolar hemorrhage, opportunistic infection (e.g., CMV), hyperglycemia, elevated creatinine, hyponatremia, hypocalcemia, acute renal failure, death"
323,TRULICITY,all-concat,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal Pain, Decreased Appetite, Dyspepsia, Fatigue, Gastrointestinal Adverse Reactions, Constipation, Flatulence, Abdominal Distension, Gastroesophageal Reflux Disease, Eructation, Documented Symptomatic Hypoglycemia, Severe Hypoglycemia, Heart Rate Increase, Tachycardia Related Adverse Reactions, Sinus Tachycardia, Immunogenicity, Anti-drug Antibodies, Antibodies against native GLP-1, Systemic Hypersensitivity, Severe Urticaria, Systemic Rash, Facial Edema, Lip Swelling, Injection-site Reactions, Injection-site Rash, Erythema, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase Increase, Lipase Increase, Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), Death"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, death"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis"
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure, jaundice, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, gout flare, cardiovascular thromboembolic events, myocardial infarction (MI), stroke, death."
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, embryofetal toxicity, thrombocytopenia, agranulocytosis, death"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, spinal or cervical cord compression (SCC), back pain, paralysis of limbs, urinary incontinence, fecal incontinence, death"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, hypersensitivity reactions, image interpretation errors, radiation risk"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
331,XALKORI,all-concat,"Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Vision disorders, visual impairment, photopsia, blurred vision, vitreous floaters, Neuropathy, sensory neuropathy, Renal cysts, local cystic invasion, abscess formation, renal abscesses, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, nausea, elevated transaminases, vomiting, constipation, diarrhea, edema, pyrexia, upper respiratory infection, decreased appetite, dysgeusia, abdominal pain, dizziness, headache, weight increased, pain in extremity, muscle spasm, eye disorders, gastrointestinal disorders, infections and infestations, musculoskeletal and connective tissue disorders, nervous system disorder, respiratory, thoracic and mediastinal disorders, general disorders and administration site conditions, Neutropenia, Lymphopenia, ALT elevation, AST elevation, Hypophosphatemia, Hypokalemia, Electrocardiogram QT prolonged, Dysphagia, Dyspepsia, fatigue, rash, syncope, hepatic failure, Embryofetal Toxicity, death"
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, flu-like symptoms, allergic dermatitis, localized allergic reaction, swelling, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, corneal exposure, ulceration, ectropion, death"
333,XIAFLEX,all-concat,"Tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymoses, penile bruising, penile swelling, injection site swelling, penile pain, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, hypersensitivity reactions, anaphylaxis, flexor tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, tear, IgE-anti-drug antibodies, allergic reactions (pruritus), ecchymosis, injection site hemorrhage, penile ecchymosis, penile hematoma, ecchymosis/contusion, injection site hemorrhage, penile hematoma, penile ecchymosis, death."
334,XTANDI,all-concat,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, gynecomastia, dysgeusia, restless legs syndrome, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, fall-related injuries, hypertensive crisis, death"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, urticaria, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), Stevens-Johnson syndrome, toxic epidermal necrolysis, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hypophysitis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, hypothyroidism, adrenal crisis, nephritis, death"
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, renal failure acute, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis, death"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, pyrexia, diarrhea, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, ALT elevations, AST elevations, GGT increased, hypertriglyceridemia, hyperglycemia, hypoglycemia, hyponatremia, lymphocyte count decreased, lymphocyte count increased, neutrophil count decreased, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased, death"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Fatigue, Decreased Appetite, Constipation, Rash, Dyspnea, Dehydration, Convulsion, Pneumonia, Dyspepsia, Gastroesophageal Reflux Disease, Dysphagia, Asthenia, Maculopapular Rash, Acneiform Dermatitis, Neuropathy, Paresthesia, Muscular Weakness, Gait Disturbance, Peripheral Neuropathy, Hypoesthesia, Peripheral Sensory Neuropathy, Dysesthesia, Neuralgia, Peripheral Motor Neuropathy, Hypotonia, Polyneuropathy, Vision Disorder, Vision Impairment, Blurred Vision, Photopsia, Accommodation Disorder, Presbyopia, Reduced Visual Acuity, Prolonged QT Interval, Hemoglobin Decreased, Alanine Transaminase Increased, Aspartate Transaminase Increased, Creatinine Increased, Glucose Increased, Phosphate Decreased, Lipase Increased, Bilirubin Increased, Respiratory Failure, Pneumothorax, Gastric Hemorrhage, General Physical Health Deterioration, Pulmonary Tuberculosis, Cardiac Tamponade, Sepsis, death"
339,ZYTIGA,all-concat,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, non-infectious pneumonitis, myopathy, rhabdomyolysis, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, myocardial ischemia, myocardial infarction, death"
